Endoscopic stenting in benign pancreatic diseases

Area of Science:

• Gastroenterology
• Endoscopic Therapy
• Pancreatic Diseases

Background:

• Endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) are key tools in managing pancreatic diseases.
• Endoscopic stent placement is integral to treating numerous pancreatic pathologies.

Purpose of the Study:

• To review and update current techniques, indications, and outcomes of endoscopic pancreatic duct stent placement.
• To discuss the evolving role of endoscopic therapy in pancreatic disease management.

Main Methods:

• Review of current literature on endoscopic pancreatic duct stent placement.
• Discussion of techniques and indications for stenting in acute and chronic pancreatitis.

Main Results:

• Endoscopic stenting is vital for treating chronic pancreatitis, pseudocysts, duct injuries, fistulae, and pancreatitis complications.
• Stents effectively reduce intraductal hypertension, bypass stones, restore patency, seal duct disruptions, drain collections, and prevent post-ERCP pancreatitis.

Conclusions:

• Endoscopic pancreatic duct stenting is a cornerstone in managing a wide spectrum of pancreatic diseases.
• The application of endoscopic therapy, particularly stenting, continues to expand, offering significant benefits for patients.